Back to top
more

Zoetis (ZTS)

(Delayed Data from NYSE)

$190.03 USD

190.03
1,697,655

-0.96 (-0.50%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $189.97 -0.06 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

PCRX vs. ZTS: Which Stock Should Value Investors Buy Now?

PCRX vs. ZTS: Which Stock Is the Better Value Option?

Sheraz Mian headshot

Top Research Reports for Amgen, BHP, Altria & Others

Today's Research Daily features new research reports on 16 major stocks, including Amgen (AMGN), BHP Group (BHP) and Altria Group (MO).

Zoetis' (ZTS) Q1 Earnings Beat Estimates, Revenues In Line

Zoetis (ZTS) beats on earnings in the first quarter of 2020 while sales meet estimates. Domestic revenues bumped up owing to growth in new parasiticide products and a robust dermatology portfolio.

Zoetis (ZTS) Q1 Earnings and Revenues Top Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 7.95% and 1.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Kinjel Shah headshot

Drug/Biotech Stock Q1 Earnings Due on May 6: ZTS, ALXN & More

Let us take a look at five drug/biotech companies due to release their first-quarter financial results on May 6.

Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?

Zoetis (ZTS) will provide pipeline updates along with financial numbers for the first quarter in its impending earnings release.

Zoetis (ZTS) Expected to Beat Earnings Estimates: Should You Buy?

Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Zoetis (ZTS) Keep the Earnings Surprise Streak Alive?

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

GRFS vs. ZTS: Which Stock Should Value Investors Buy Now?

GRFS vs. ZTS: Which Stock Is the Better Value Option?

GRFS vs. ZTS: Which Stock Should Value Investors Buy Now?

GRFS vs. ZTS: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Tesla, Zoetis, Target, Boston Scientific and Moody's

The Zacks Analyst Blog Highlights: Tesla, Zoetis, Target, Boston Scientific and Moody's

Sheraz Mian headshot

Top Research Reports for Tesla, Zoetis, Target

Today's Research Daily features new research reports on 16 major stocks, including Tesla (TSLA), Zoetis (ZTS) and Target (TGT).

Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?

Style Box ETF report for DEF

Zoetis (ZTS) Down 13.4% Since Last Earnings Report: Can It Rebound?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PCRX or ZTS: Which Is the Better Value Stock Right Now?

PCRX vs. ZTS: Which Stock Is the Better Value Option?

PCRX vs. ZTS: Which Stock Is the Better Value Option?

PCRX vs. ZTS: Which Stock Is the Better Value Option?

Stock Market News for Feb 14, 2020

U.S. stocks slid Thursday following a massive jump in coronavirus cases.

Zoetis' (ZTS) Earnings and Revenues Beat Estimates in Q4

Zoetis (ZTS) beats on both earnings and sales in the fourth quarter of 2019.

Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?

Zoetis Inc. (ZTS) will provide financial numbers for fourth-quarter 2019 and pipeline updates on Feb 13.

Zoetis (ZTS) Earnings Expected to Grow: Should You Buy?

Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMRX vs. ZTS: Which Stock Is the Better Value Option?

AMRX vs. ZTS: Which Stock Is the Better Value Option?

Can Zoetis (ZTS) Keep the Earnings Surprise Streak Alive?

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?

Style Box ETF report for DEF

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Texas Instruments, Charter, Lowe's, Caterpillar and Zoetis

The Zacks Analyst Blog Highlights: Texas Instruments, Charter, Lowe's, Caterpillar and Zoetis